Blog

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Blog
Oct 27, 2024, 19:45 | Blog
Justine Anderson: Redesigning Care Coordination
Justine Anderson, Oncology Fellow at the Icahn School of Medicine at Mount Sinai, shared a…
Oct 27, 2024, 19:36 | Blog
Claire Fletcher: Proud to see Nil Grunberg receiving her PCF Science Young Investigator Award
Claire Fletcher, Group Leader and Advanced Research Fellow within the Department of Surgery and Cancer…
Oct 27, 2024, 19:33 | Blog
Brandon Mahal: Talent knows no borders
Brandon Mahal, Vice Chair and Residency Program Director at Sylvester Comprehensive Cancer Center, shared a…
Oct 27, 2024, 19:31 | Blog
Karen Knudsen: Kudos to friend and fellow Mally Roncal for being inducted into the Forbes 50 Over 50
Karen Knudsen, CEO of the American Cancer Society, shared a post on LinkedIn: "Well look who…
Oct 27, 2024, 19:30 | Blog
Sally Wolf: Addressing the need to ensure no one chooses between chemo and childcare
Sally Wolf, CEO and Founder of LightWorks, shared a post on LinkedIn: "Last night, my mom,…
Oct 27, 2024, 19:28 | Blog
Karen Knudsen: An afternoon of shared experiences and sorority
Karen Knudsen, CEO of the American Cancer Society, shared a post on LinkedIn: "What a…
Oct 27, 2024, 19:27 | Blog
The clinical trials of today are tomorrow's standard of care - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn: "The clinical trials of today are tomorrow's…
Oct 27, 2024, 19:24 | Blog
David Callaway: The Cancer MoonShot top 5 priorities
David Callaway, Global Health Security and Sustainability Officer at Advocate Health, shared a post on…
Oct 27, 2024, 17:45 | Blog
Rituraj Upadhyay: Risk-Stratified radiation for Pediatric Cancers
Rituraj Upadhyay, Radiation Oncology Chief Resident at The Ohio State University Wexner Medical Center, shared…
Oct 27, 2024, 17:41 | Blog
Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared on X: "S1803 Ph3…
All: 17473 Posts: 1871 - 1880
Special Coverage